Major moves in pharma and biotech partnering are reshaping the landscape. For ADC companies, the challenge lies in standing out, validating their offerings, and securing clinical-ready assets amidst this whirlwind of activity.

Why Attend?

• Cuts through the noise of partnership events to gather a targeted critical mass of 100+ ADC companies

• Provides a platform for networking and fast-tracking the search and evaluation of earlier development assets

• Empowers participants to navigate the complex partnering landscape with confidence by significantly improving the alignment, efficiency, and yield of conversations

See the event details here.